Skip to search formSkip to main contentSkip to account menu

Purified Poloxamer 188

Known as: MST-188 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Vepoloxamer

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Protective Effect of Poloxamer-188 on Platelet Functions
Background: Poloxamer-188 (MST-188) is effective in the repair/recovery of damaged cell membranes. MST-188 is a promising agent… 
2015
2015
Abstract W P101: Combination of MST-188 and Tissue Plasminogen Activator Extends the Therapeutic Window of Stroke
Background and Purpose: The utilization of tissue plasminogen activator (tPA) for stroke treatment is hampered by its narrow… 
2014
2014
Abstract 13191: Short (2 hour) Intravenous Infusion of Purified Poloxamer-188 (MST-188) Elicits Prolonged (1-2 weeks) Improvement in Biomarkers in Dogs with Advanced Heart Failure
Background: MST-188 (purified poloxamer 188) is a rheologic and membrane stabilizing agent shown to improve LV function in… 
2014
2014
Facilitation of urokinase‐mediated fibrinolysis by MST‐188 (833.7)
Introduction MST‐188 (Mast Therapeutics, San Diego, CA.) is a highly purified form of the , triblock copolymer poloxamer 188. It… 
2012
2012
The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart
Background Lipid-emulsion propofol (LP) has cardioprotective effects against ischemia-reperfusion injury, but it has lipid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)